Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

FDA clears Palladio to begin phase II study of lixivaptan in ADPKD

May 9, 2018

FDA approves Myrbetriq in combination with solifenacin for overactive bladder

May 8, 2018

Novel farnesoid X receptor agonists described by Enanta Pharmaceuticals

April 25, 2018

FDA approves Jynarque to slow kidney function decline in adults with ADPKD

April 25, 2018

Reata offers update on ongoing CARDINAL study of bardoxolone in Alport syndrome

April 12, 2018

Recordati acquires rights to Cystagon

April 9, 2018

Topline results from phase II study of fostamatinib in IgA nephropathy

April 4, 2018

Retrophin initiates pivotal phase III DUPLEX study of sparsentan

April 4, 2018

Urovant initiates phase III trial of vibegron in overactive bladder

March 29, 2018

Vifor Pharma grants Zeria license to develop and market Veltassa in Japan

March 29, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...